Correlation Between Viatris and Dr Reddys

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viatris and Dr Reddys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viatris and Dr Reddys into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viatris and Dr Reddys Laboratories, you can compare the effects of market volatilities on Viatris and Dr Reddys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viatris with a short position of Dr Reddys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viatris and Dr Reddys.

Diversification Opportunities for Viatris and Dr Reddys

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between Viatris and RDY is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Viatris and Dr Reddys Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dr Reddys Laboratories and Viatris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viatris are associated (or correlated) with Dr Reddys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dr Reddys Laboratories has no effect on the direction of Viatris i.e., Viatris and Dr Reddys go up and down completely randomly.

Pair Corralation between Viatris and Dr Reddys

Given the investment horizon of 90 days Viatris is expected to generate 0.69 times more return on investment than Dr Reddys. However, Viatris is 1.45 times less risky than Dr Reddys. It trades about -0.32 of its potential returns per unit of risk. Dr Reddys Laboratories is currently generating about -0.32 per unit of risk. If you would invest  1,242  in Viatris on November 2, 2024 and sell it today you would lose (100.00) from holding Viatris or give up 8.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Viatris  vs.  Dr Reddys Laboratories

 Performance 
       Timeline  
Viatris 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Viatris are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Viatris is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Dr Reddys Laboratories 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dr Reddys Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Viatris and Dr Reddys Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viatris and Dr Reddys

The main advantage of trading using opposite Viatris and Dr Reddys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viatris position performs unexpectedly, Dr Reddys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dr Reddys will offset losses from the drop in Dr Reddys' long position.
The idea behind Viatris and Dr Reddys Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Stocks Directory
Find actively traded stocks across global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.